Follow-The-Filings

VVOS Vivos Therapeutics

Vivos Therapeutics earnings company data as of 7:18 PM ET 8/21

History

1 period · newest first · EPS & Rev stacked

Period Date Metric Estimate Actual Result
FY2026 Q2 14 Aug EPS -0.31
Rev

SEC filings

Recent issuer filings from EDGAR · 25 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 7.01,9.01
10-Q
8-K 7.01,9.01
8-K 1.01,5.02,9.01
8-K 1.01,3.02,5.03,9.01
8-K 1.01,7.01,9.01
8-K 1.01,7.01,9.01
8-K 8.01,9.01
8-K 1.01,2.03,3.01,3.02,7.01,9.01
10-Q
424B3
8-K 3.01
10-K
8-K 2.02,9.01
8-K 1.01,3.02,9.01
8-K 5.02
8-K 1.01,3.02,9.01
8-K 1.01,2.03,3.02,9.01
424B3
8-K 8.01,9.01
8-K 1.01,2.03,9.01
10-Q
8-K 2.02,9.01
8-K 5.07
8-K 8.01,9.01

Insider forms

Form 3 / 4 / 5 from EDGAR · 3 rows shown

Filed Form Detail Links
4 Period Jul 31, 2026
4 Period Jun 30, 2026
4 Period Mar 31, 2026

Consensus estimates · SEC filings remain the official record · not investment advice